Molecular Simulation Study Reveals How Propolis Compounds Cross the Blood-Brain Barrier
Researchers used all-atom molecular dynamics simulations to study how two compounds derived from propolis—CAPE and Artepillin-C—cross the blood-brain barrier. CAPE showed favorable permeability with low energy barriers, while Artepillin-C faced substantial resistance and poor permeability. The findings provide mechanistic insights that could guide the design of neurotherapeutic drugs.
A new computational study employed advanced molecular dynamics simulations to examine the passive permeation of two bioactive propolis-derived compounds across a realistic blood-brain barrier lipid bilayer model. Using steered molecular dynamics and umbrella sampling techniques, researchers calculated free energy profiles and permeability metrics for Caffeic Acid Phenethyl Ester (CAPE) and Artepillin-C (ARC). CAPE demonstrated favorable permeability characteristics with a modest energy barrier (~2-3 kcal/mol) at the lipid headgroup region and minimal resistance in the hydrophobic core. In contrast, ARC exhibited substantial energetic barriers within the membrane core, resulting in strongly unfavorable permeability. The heterogeneous lipid model used in the simulations reproduced experimentally consistent membrane properties, demonstrating how lipid composition influences transport energetics. These atomistic-level insights could inform the rational design of neuroactive therapeutics.
What's missing
The study's limitations include reliance on computational simulations rather than experimental validation; the extent to which these in silico predictions correlate with actual in vitro or in vivo BBB permeability remains to be experimentally confirmed. Additionally, the study does not address active transport mechanisms or the role of efflux transporters, which can significantly influence BBB permeability in biological systems.
What different sources said
- bioRxivCenter
Atomistic Simulation of Blood Brain Barrier Permeability of Propolis Derived Natural Compounds
Related
Study Links Specific Brain Stimulation Frequency to Speech Speed in Parkinson's Disease
Researchers found that low-frequency deep brain stimulation in the subthalamic nucleus selectively reduces a specific frequency band (15-23 Hz) associated with slower speech in Parkinson's disease patients. The study suggests this neural activity pattern could serve as a biomarker for speech tempo modulation. This finding may help optimize deep brain stimulation treatments to improve speech problems in Parkinson's patients.
Researchers Identify Complete Bacterial Pathway for Converting Bilirubin to Urobilinogen in Human Gut
Scientists have identified the complete enzymatic pathway by which gut bacteria convert bilirubin (a heme breakdown product) into urobilinogen, involving two enzymes: BilR and BilV. The discovery reveals that bilirubin metabolism requires two sequential reactions that can occur in either order, with BilV being a flavin-dependent enzyme widely distributed across gut bacteria. This finding is significant because bilirubin and its derivatives are linked to inflammatory and metabolic disorders, and understanding this pathway could enable better studies of how gut bacteria influence human health.
FEABAS: New Software Tool Improves Electron Microscopy Image Alignment for Brain Mapping
Researchers have developed FEABAS, an open-source software package that aligns and stitches millions of electron microscope images into coherent 3D volumes for neural circuit mapping. The tool uses adaptive mesh modeling and finite element methods to handle common imaging artifacts like wrinkles, folds, and tears without requiring intensive deep learning or manual editing. This advancement could make volume electron microscopy more accessible and practical for broader neuroscience research applications.